The natural history of hypertension in older adults: a study of two Finnish generational cohorts born 20 years apart

We conducted a comparative analysis of hypertension prevalence, progression, and treatment in two Finnish population-based cohorts comprising older adults born 20 years apart. The study covered data from pre- and post-HYVET Study eras and spanned the onset of the COVID-19 pandemic. All 70-year-old h...

Full description

Saved in:
Bibliographic Details
Published in:Blood pressure 2024-12, Vol.33 (1), p.2368798
Main Authors: Lääti, Adriana, Teppo, Konsta, Vire, Jenni, Viitanen, Matti, Langén, Ville
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Ageing
Antihypertensive Agents - therapeutic use
antihypertensive medication
Blood Pressure - drug effects
blood pressure control
Cohort Studies
COVID-19 - epidemiology
COVID-19 era
Disease Progression
Female
Finland - epidemiology
Humans
hypertension
Hypertension - drug therapy
Hypertension - epidemiology
Hypertension - physiopathology
Male
Medicin och hälsovetenskap
Prevalence
prospective cohort study
SARS-CoV-2
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We conducted a comparative analysis of hypertension prevalence, progression, and treatment in two Finnish population-based cohorts comprising older adults born 20 years apart. The study covered data from pre- and post-HYVET Study eras and spanned the onset of the COVID-19 pandemic. All 70-year-old home-dwelling citizens of Turku, in Southwest Finland, were invited to participate in the survey in 1990 (1920-born TUVA cohort) and in 2010 (1940-born UTUVA cohort) with a 25-year follow-up plan. The analyses included those with available data for systolic and diastolic blood pressure (BP), yielding 1015 TUVA and 888 UTUVA participants at baseline. Biomarkers associated with BP were analysed with - and chi-square tests. At baseline, 83.4% of TUVA and 74.3% of UTUVA participants had uncontrolled BP, with respective antihypertensive medication usage at 36.0% and 55.9% (  
ISSN:0803-7051
1651-1999
1651-1999
DOI:10.1080/08037051.2024.2368798